Kyung-Hoon Lee

CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment.

David A. Flockhart, Daniel F. Hayes, Richard M. Weinshilboum, 2005, Journal of the National Cancer Institute.

A Population Pharmacokinetic Model with Time‐Dependent Covariates Measured with Errors

Lang Li, Xihong Lin, Morton B. Brown, 2004, Biometrics.

Quantification of tamoxifen and three metabolites in plasma by high-performance liquid chromatography with fluorescence detection: application to a clinical trial.

D. Flockhart, Z. Desta, Bryan A. Ward, 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Factors affecting the interindividual variability of warfarin dose requirement in adult Korean patients.

Hee-Jin Kim, Seonwoo Kim, Soo-Youn Lee, 2007, Pharmacogenomics.

Determination of plasma warfarin concentrations in Korean patients and its potential for clinical application.

Hee-Jin Kim, M. Kwon, Soo-Youn Lee, 2009, The Korean journal of laboratory medicine.

Angiotensin II type 1 receptor 1166A/C polymorphism in association with blood pressure response to exogenous angiotensin II

Hyeong-Seok Lim, Kyun-Seop Bae, Sang-Goo Shin, 2006, European Journal of Clinical Pharmacology.

Pharmacological Characterization of 4-hydroxy-N-desmethyl Tamoxifen, a Novel Active Metabolite of Tamoxifen

T. Skaar, J. Trebley, Michael D. Johnson, 2004, Breast Cancer Research and Treatment.

Estimation and Inference for a Spline‐Enhanced Population Pharmacokinetic Model

Lang Li, Morton B. Brown, Lang Li, 2002, Biometrics.